A Novel Biomarker Panel Examining Response to Gemcitabine with or without Erlotinib for Pancreatic Cancer Therapy in NCIC Clinical Trials Group PA.3.

by David B Shultz, Jonathan Pai, Wayland Chiu, Kendall Ng, Madeline G Hellendag, Gregory Heestand, Daniel T Chang, Dongsheng Tu, Malcolm J Moore, Wendy R Parulekar, Albert C Koong
Published 2016-01-01

Clinicopathologic and Treatment Features of Long-Term Surviving Brain Metastasis Patients

by Archya Dasgupta, Jayson Co, Jeff Winter, Barbara-Ann Millar, Normand Laperriere, Derek S. Tsang, Monique van Prooijen, Andrei Damyanovich, Robert Heaton, Catherine Coolens, Mark Bernstein, Paul Kongkham, Gelareh Zadeh, Alejandro Berlin, Tatiana Conrad, Fabio Y. Moraes, David B. Shultz
Published 2021-01-01

Neurological Death is Common in Patients With EGFR Mutant Non-Small Cell Lung Cancer Diagnosed With Brain Metastases

by Matthew Ramotar, HBSc, Sierra Barnes, BSc, Fabio Moraes, MD, Archya Dasgupta, MD, Normand Laperriere, MD, Barbara-Ann Millar, MBChB, Alejandro Berlin, MD, MSc, Tatiana Conrad, MD, Monique van Prooijen, PhD, Andrei Damyanovich, PhD, Robert Heaton, PhD, Young-Bin Cho, PhD, Catherine Coolens, PhD, Geoffrey Liu, MSc, MD, Frances A. Shepherd, MD, Penelope Bradbury, MBChB, Natasha Leighl, MSc, MD, Mark Bernstein, MD, MSc, Gelareh Zadeh, MD, PhD, Paul Kongkham, MD, PhD, Mark Doherty, MB, BCh, BAO, David B. Shultz, MD, PhD
Published 2020-05-01